Prednisolone

Articles · Medicine Compliance Aid Stability · Lactation Safety Information ·
52388000

Articles

Medicine Compliance Aid Stability

generic · Zentiva

Zentiva
generic
Tablets 25mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light. Protect from moisture. Store in airtight containers. Hygroscopic. Due to the hygroscopic nature of the tablets, maximum 8 day expiry in a MCA.
12th February 2015

generic · Actavis UK Ltd

Actavis UK Ltd
generic
Tablets 1mg, 5mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light. Protect from moisture. Store in airtight containers. Hygroscopic. Due to the hygroscopic nature of the tablets, maximum 8 day expiry in a MCA.
12th February 2015

Deltacortril · Alliance Pharmaceuticals

Alliance Pharmaceuticals
Deltacortril
Tablets e/c 2.5mg, 5mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light. Protect from moisture. Store in airtight containers. Hygroscopic. Due to the hygroscopic nature of the tablets, maximum 8 day expiry in a MCA.
12th February 2015

Lactation Safety Information

As a systemic corticosteroid

As a systemic corticosteroid
Limited published evidence of safety although extensive experience of safe use in breastfeeding
Small amounts in breast milk
Doses up to 50mg daily unlikely to cause adverse effects in the infant
24th September 2020

As an immunosuppressant

As an immunosuppressant
Limited published evidence of safety although extensive experience of safe use in breastfeeding’
Small amounts in breast milk
Doses up to 50mg daily unlikely to cause adverse effects in the infant
24th September 2020

Local injection

Local injection
24th September 2020

In the ear

In the ear
24th September 2020

Oral / rectal for inflammatory bowel disease

Oral / rectal
for inflammatory bowel disease
-
Limited published evidence of safety although extensive experience of safe use in breastfeeding
Small amounts in breast milk after oral administration
Doses up to 50mg orally daily unlikely to cause adverse effects in the infant
24th September 2020